Bacterial Vaginosis Treatment Guidelines

Recommended First-Line Regimens for Non-Pregnant Women

The Centers for Disease Control and Prevention (CDC) recommends metronidazole 500 mg orally twice daily for 7 days as first-line therapy for symptomatic bacterial vaginosis in non-pregnant women, with a cure rate of 84% at 7-10 days post-treatment 1, 2, 3, 4
The CDC guidelines provide three equally effective first-line options, including metronidazole 500 mg orally twice daily for 7 days, clindamycin cream 2% one full applicator (5 g) intravaginally at bedtime for 7 days, and metronidazole gel 0.75% one full applicator (5 g) intravaginally twice daily for 5 days, with comparable cure rates of 78-84% 1, 2, 3, 4
Clindamycin cream 2% is an effective alternative, with a cure rate of 82% 1
Metronidazole gel 0.75% is also an effective option, with a cure rate of 75% 1

The CDC recommends metronidazole 2 g orally as a single dose as an alternative regimen, but notes that it has lower efficacy compared to the 7-day regimen 1
Clindamycin 300 mg orally twice daily for 7 days is another alternative regimen, but its efficacy is lower compared to the first-line options 1

For recurrent disease, the CDC recommends treating with metronidazole 500 mg orally twice daily for 10-14 days, followed by suppressive therapy with metronidazole gel 0.75% twice weekly for 3-6 months, which reduces recurrence rates from approximately 60% to 25% 5

The CDC advises patients to avoid all alcohol consumption during metronidazole treatment and for 24 hours after completion due to disulfiram-like reactions 1, 2, 3, 4, 5
Patients using clindamycin cream should be warned that it is oil-based and may weaken latex condoms and diaphragms 1, 2, 3, 4

For symptomatic pregnant women after the first trimester, the CDC recommends treating with metronidazole 250 mg orally three times daily for 7 days 5
High-risk pregnant women (those with prior preterm delivery) should receive treatment even if asymptomatic, as bacterial vaginosis is associated with premature rupture of membranes, preterm labor, and preterm birth 1, 2, 3, 4

The CDC does not recommend routinely treating sexual partners, as multiple clinical trials demonstrate that partner treatment does not affect cure rates, recurrence rates, or treatment response in women 1, 2, 5

The CDC recommends treating all women (symptomatic or asymptomatic) with bacterial vaginosis before surgical abortion procedures to reduce the risk of post-abortion pelvic inflammatory disease 1, 2, 3

Follow-up visits are unnecessary if symptoms resolve, but recurrence is common and any of the recommended regimens may be used to treat recurrent episodes 1, 2